GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (STU:LLY) » Definitions » Cyclically Adjusted Book per Share

Eli Lilly and Co (STU:LLY) Cyclically Adjusted Book per Share : €11.58 (As of Mar. 2024)


View and export this data going back to 1970. Start your Free Trial

What is Eli Lilly and Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Eli Lilly and Co's adjusted book value per share for the three months ended in Mar. 2024 was €12.402. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €11.58 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Eli Lilly and Co's average Cyclically Adjusted Book Growth Rate was -2.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.10% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -1.10% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 0.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Eli Lilly and Co was 8.80% per year. The lowest was -2.00% per year. And the median was 4.40% per year.

As of today (2024-05-20), Eli Lilly and Co's current stock price is €707.50. Eli Lilly and Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €11.58. Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is 61.10.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 63.09. The lowest was 4.09. And the median was 8.27.


Eli Lilly and Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Eli Lilly and Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Cyclically Adjusted Book per Share Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.51 9.96 11.16 11.89 11.24

Eli Lilly and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.77 11.68 11.89 11.24 11.58

Competitive Comparison of Eli Lilly and Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Cyclically Adjusted PB Ratio falls into.



Eli Lilly and Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Eli Lilly and Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=12.402/131.7762*131.7762
=12.402

Current CPI (Mar. 2024) = 131.7762.

Eli Lilly and Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 11.846 100.560 15.523
201409 12.315 100.428 16.159
201412 11.226 99.070 14.932
201503 12.423 99.621 16.433
201506 11.791 100.684 15.432
201509 12.239 100.392 16.065
201512 12.102 99.792 15.981
201603 12.211 100.470 16.016
201606 11.802 101.688 15.294
201609 12.582 101.861 16.277
201612 12.062 101.863 15.604
201703 11.890 102.862 15.232
201706 11.399 103.349 14.534
201709 11.346 104.136 14.358
201712 8.905 104.011 11.282
201803 10.782 105.290 13.494
201806 9.210 106.317 11.415
201809 10.499 106.507 12.990
201812 8.173 105.998 10.161
201903 2.261 107.251 2.778
201906 2.547 108.070 3.106
201909 3.199 108.329 3.891
201912 2.450 108.420 2.978
202003 2.912 108.902 3.524
202006 3.800 108.767 4.604
202009 4.284 109.815 5.141
202012 4.848 109.897 5.813
202103 6.040 111.754 7.122
202106 5.592 114.631 6.428
202109 6.893 115.734 7.848
202112 8.333 117.630 9.335
202203 8.913 121.301 9.683
202206 8.507 125.017 8.967
202209 10.704 125.227 11.264
202212 10.581 125.222 11.135
202303 11.010 127.348 11.393
202306 10.757 128.729 11.012
202309 11.075 129.860 11.238
202312 10.405 129.419 10.594
202403 12.402 131.776 12.402

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Eli Lilly and Co  (STU:LLY) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Eli Lilly and Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=707.50/11.58
=61.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Eli Lilly and Co was 63.09. The lowest was 4.09. And the median was 8.27.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Eli Lilly and Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Eli Lilly and Co (STU:LLY) Business Description

Industry
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.